Aurion Biotech celebrates commercial launch of neltependocel (Vyznova) in Japan
Aurion Biotech announced the commercial launch of neltependocel (Vyznova) in Japan for the treatment of bullous keratopathy of the cornea. Vyznova has received both regulatory and reimbursement approval in Japan. Bullous keratopathy is a sight-threatening …